K. O'Donnell

发表

Hepatitis C virus infection in the asymptomatic British blood donor

J. Neuberger, E. Elias, D. Mutimer, 1995, Journal of viral hepatitis.

Ante-natal screening and post-natal follow-up of hepatitis B in the West Midlands of England.

D. Mutimer, E. Boxall, S. Bhattacharya, 2008, QJM : monthly journal of the Association of Physicians.

Inferior response of Asian vs non‐Asian hepatitis C genotype 3 infection to combination antiviral therapy

D. Mutimer, D. Freshwater, K. O'Donnell, 2007, Journal of viral hepatitis.

High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation.

D. Pillay, P. Cane, P. Mcmaster, 1999, Journal of hepatology.

Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection.

E. Elias, P. Stålhandske, D. Mutimer, 1997, Transplantation.

Selection of multiresistant hepatitis B virus during sequential nucleoside-analogue therapy.

D. Pillay, P. Cane, E. Elias, 2000, The Journal of infectious diseases.

Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir

D. Pillay, P. Cane, D. Mutimer, 2001, Gut.

Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient

D. Pillay, P. Cane, S. Hübscher, 2000, Gut.

Additive antiviral effects of lamivudine and alpha-interferon in chronic hepatitis B infection.

D. Pillay, P. Cane, E. Elias, 2000, Antiviral therapy.

Selection of hepatitis B surface “escape” mutants during passive immune prophylaxis following liver transplantation: potential impact of genetic changes on polymerase protein function

E. Elias, A. Owsianka, D. Mutimer, 1999, Gut.

Disappointing results of combination therapy for HCV?

D. Mutimer, G. Haydon, K. O'Donnell, 2006, Gut.

HIV-1 sensitivity to zidovudine and clinical outcome in children

E. Walter, T. Rudoll, E. Connor, 1992, The Lancet.

Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients.

E. Elias, D. Mutimer, J. Shaw, 1997, Transplantation.

Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity

J. Neuberger, E. Elias, D. Mutimer, 1994, BMJ.

Quantitation of cytomegalovirus in the blood of liver transplant recipients.

J. Neuberger, P. Mcmaster, B. Gunson, 1995, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Enhanced (cytomegalovirus) viral replication after transplantation for fulminant hepatic failure.

E. Elias, D. Mutimer, J. Shaw, 1997, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Results of combination treatment with pegylated interferon and ribavirin in cirrhotic patients with hepatitis C infection

Peter Nightingale, P. Nightingale, D. Mutimer, 2006, Liver international : official journal of the International Association for the Study of the Liver.

Weight loss during pegylated interferon and ribavirin treatment of chronic hepatitis C *

D. Mutimer, D. Freshwater, M. Seyam, 2005, Journal of viral hepatitis.

Incidence and characterization of serum transaminases elevations in pegylated interferon and ribavirin treated patients with chronic hepatitis C

D. Thorburn, D. Mutimer, P. Thurairajah, 2007, Alimentary pharmacology & therapeutics.

Ante-natal screening and post-natal follow-up of hepatitis B in the West Midlands of England.

D. Mutimer, E. Boxall, S. Bhattacharya, 2008, QJM : monthly journal of the Association of Physicians.